Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Br, Feb. 06,
2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest
key findings for all current investors, traders, and shareholders of Edwards Lifesciences Corporation (NYSE:EW), Zimmer Biomet
Holdings, Inc. (NYSE:ZBH), American Outdoor Brands Corporation (NASDAQ:AOBC), Radius Health, Inc. (NASDAQ:RDUS), Kaman Corporation
(NYSE:KAMN), and FARO Technologies, Inc. (NASDAQ:FARO), including updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
EW DOWNLOAD: http://Fundamental-Markets.com/register/?so=EW
ZBH DOWNLOAD: http://Fundamental-Markets.com/register/?so=ZBH
AOBC DOWNLOAD: http://Fundamental-Markets.com/register/?so=AOBC
RDUS DOWNLOAD: http://Fundamental-Markets.com/register/?so=RDUS
KAMN DOWNLOAD: http://Fundamental-Markets.com/register/?so=KAMN
FARO DOWNLOAD: http://Fundamental-Markets.com/register/?so=FARO
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Edwards Lifesciences Corporation (NYSE:EW), Zimmer Biomet Holdings, Inc. (NYSE:ZBH), American Outdoor Brands Corporation
(NASDAQ:AOBC), Radius Health, Inc. (NASDAQ:RDUS), Kaman Corporation (NYSE:KAMN), and FARO Technologies, Inc. (NASDAQ:FARO) on a
fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business
strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are
available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed February 4th,
2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
EDWARDS LIFESCIENCES CORPORATION (EW) REPORT OVERVIEW
Edwards Lifesciences' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Edwards Lifesciences reported revenue
of $906.60MM vs $821.50MM (up 10.36%) and analysts estimated basic earnings per share $1.08 vs $0.81 (up 33.33%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Edwards Lifesciences reported revenue of $3,435.30MM vs $2,963.70MM (up
15.91%) and analysts estimated basic earnings per share $2.77 vs $2.67 (up 3.75%). Analysts expect earnings to be released on April
23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was
$1.22. The estimated EPS forecast for the next fiscal year is $5.84 and is expected to report on January 30th, 2020.
To read the full Edwards Lifesciences Corporation (EW) report, download it here: http://Fundamental-Markets.com/register/?so=EW
-----------------------------------------
ZIMMER BIOMET HOLDINGS, INC. (ZBH) REPORT OVERVIEW
Zimmer Biomet's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Zimmer Biomet reported revenue of
$1,836.70MM vs $1,813.10MM (up 1.30%) and analysts estimated basic earnings per share $0.80 vs $0.49 (up 63.27%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Zimmer Biomet reported revenue of $7,824.10MM vs $7,683.90MM (up 1.82%)
and analysts estimated basic earnings per share $8.98 vs $1.53 (up 486.93%). Analysts expect earnings to be released on April 25th,
2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $1.91. The
estimated EPS forecast for the next fiscal year is $8.37 and is expected to report on February 7th, 2020.
To read the full Zimmer Biomet Holdings, Inc. (ZBH) report, download it here: http://Fundamental-Markets.com/register/?so=ZBH
-----------------------------------------
AMERICAN OUTDOOR BRANDS CORPORATION (AOBC) REPORT OVERVIEW
American Outdoor Brands' Recent Financial Performance
For the three months ended October 31st, 2018 vs October 31st, 2017, American Outdoor Brands reported revenue of
$161.70MM vs $148.43MM (up 8.94%) and analysts estimated basic earnings per share $0.12 vs $0.06 (up 100.00%). For the twelve
months ended April 30th, 2018 vs April 30th, 2017, American Outdoor Brands reported revenue of $606.85MM vs $903.19MM (down 32.81%)
and analysts estimated basic earnings per share $0.37 vs $2.29 (down 83.84%). Analysts expect earnings to be released on March 7th,
2019. The report will be for the fiscal period ending January 31st, 2019. Reported EPS for the same quarter last year was $0.09.
The estimated EPS forecast for the next fiscal year is $0.91 and is expected to report on June 19th, 2019.
To read the full American Outdoor Brands Corporation (AOBC) report, download it here: http://Fundamental-Markets.com/register/?so=AOBC
-----------------------------------------
RADIUS HEALTH, INC. (RDUS) REPORT OVERVIEW
Radius Health's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Radius Health reported revenue of
$27.64MM vs $13.47MM (up 105.20%) and basic earnings per share -$1.09 vs -$1.31. Analysts expect earnings to be released on March
7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was
-$1.59. The estimated EPS forecast for the next fiscal year is -$3.88 and is expected to report on March 7th, 2019.
To read the full Radius Health, Inc. (RDUS) report, download it here: http://Fundamental-Markets.com/register/?so=RDUS
-----------------------------------------
KAMAN CORPORATION (KAMN) REPORT OVERVIEW
Kaman's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Kaman reported revenue of $443.06MM vs
$447.05MM (down 0.89%) and analysts estimated basic earnings per share $0.05 vs $0.58 (down 91.38%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Kaman reported revenue of $1,805.91MM vs $1,808.38MM (down 0.14%) and analysts
estimated basic earnings per share $1.80 vs $2.17 (down 17.05%). Analysts expect earnings to be released on February 25th, 2019.
The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.86. The
estimated EPS forecast for the next fiscal year is $3.68 and is expected to report on February 25th, 2019.
To read the full Kaman Corporation (KAMN) report, download it here: http://Fundamental-Markets.com/register/?so=KAMN
-----------------------------------------
FARO TECHNOLOGIES, INC. (FARO) REPORT OVERVIEW
FARO Technologies' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, FARO Technologies reported revenue of
$99.71MM vs $90.25MM (up 10.48%) and analysts estimated basic earnings per share -$0.15 vs $0.10. For the twelve months ended
December 31st, 2017 vs December 31st, 2016, FARO Technologies reported revenue of $360.92MM vs $325.58MM (up 10.85%) and analysts
estimated basic earnings per share -$0.87 vs $0.67. Analysts expect earnings to be released on February 20th, 2019. The report will
be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.50. The estimated EPS
forecast for the next fiscal year is $1.38 and is expected to report on February 20th, 2019.
To read the full FARO Technologies, Inc. (FARO) report, download it here: http://Fundamental-Markets.com/register/?so=FARO
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
